Abstract
The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Thus, alterations of the Notch signaling can lead to a variety of disorders including human malignancies. Of considerable interest, recent evidence indicates that there is a significant cross-talk between Notch and microRNAs. As a key component of the Notch-mediated transcription complex, Notch can regulate expression of a number of microRNAs; at the same time, Notch ligands, Notch receptor or Notch effectors are also subject to regulation by microRNAs. Thus, a better understanding of how Notch signaling interacts with microRNAs in the context of cancer will help identify novel biomarkers and therapeutic targets. In this review, we update on recent findings on microRNAs interacting with Notch signaling at various levels, leading to tumorigenesis or chemoresistance. We also highlight the therapeutic potential of targeting Notch signaling and related microRNAs.
Keywords: Notch signaling, microRNAs, tumorigenesis, gene silencing.
Current Drug Targets
Title:Notch-Associated MicroRNAs in Cancer
Volume: 14 Issue: 10
Author(s): Yin-Yuan Mo, Hua Tang and Lucio Miele
Affiliation:
Keywords: Notch signaling, microRNAs, tumorigenesis, gene silencing.
Abstract: The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Thus, alterations of the Notch signaling can lead to a variety of disorders including human malignancies. Of considerable interest, recent evidence indicates that there is a significant cross-talk between Notch and microRNAs. As a key component of the Notch-mediated transcription complex, Notch can regulate expression of a number of microRNAs; at the same time, Notch ligands, Notch receptor or Notch effectors are also subject to regulation by microRNAs. Thus, a better understanding of how Notch signaling interacts with microRNAs in the context of cancer will help identify novel biomarkers and therapeutic targets. In this review, we update on recent findings on microRNAs interacting with Notch signaling at various levels, leading to tumorigenesis or chemoresistance. We also highlight the therapeutic potential of targeting Notch signaling and related microRNAs.
Export Options
About this article
Cite this article as:
Mo Yin-Yuan, Tang Hua and Miele Lucio, Notch-Associated MicroRNAs in Cancer, Current Drug Targets 2013; 14 (10) . https://dx.doi.org/10.2174/13894501113149990188
DOI https://dx.doi.org/10.2174/13894501113149990188 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular Relationships of Testicular Germ Cell Tumors Determined by Partial Canonical Correlation Analysis of Gene Expression Signatures
Current Bioinformatics An overview of ABC and SLC Drug Transporter Gene Regulation
Current Drug Metabolism The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
Current Cancer Drug Targets Gonadotropin-Releasing Hormone Receptor Signaling: Biased and Unbiased
Mini-Reviews in Medicinal Chemistry Fungal Proteins with Antiproliferative and Anticancer Activities
Protein & Peptide Letters The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions
Current Vascular Pharmacology From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Prenatal Exposure of a Novel Antipsychotic Aripiprazole: Impact on Maternal, Fetal and Postnatal Body Weight Modulation in Rats
Current Drug Safety Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Nuclear Hormone Receptors and Female Reproduction
Current Molecular Medicine Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: A Hypothesis
Current Stem Cell Research & Therapy Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Current Pharmaceutical Design Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Current Organic Chemistry The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Current Medicinal Chemistry Molecular Basis of Gestational Trophoblastic Diseases
Current Molecular Medicine